Even though there is a big upfront cost (in the US), isn't the treatment with this drug a lot less expensive than not treating someone with Hep C? So shouldn't the overall costs go down?
Even though there is a big upfront cost (in the US), isn't the treatment with this drug a lot less expensive than not treating someone with Hep C? So shouldn't the overall costs go down?